Intervention

aldesleukin

ClinicalTrials.gov intervention label

Clinical trials21

Recruiting0

Common conditions25

Lead sponsors shown14

Clinical trials

21 shown

Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast CaNCT00784524 · 2008-09-01

Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung CancerNCT00569296 · 2007-11-01

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With CancerNCT01212887 · 2007-08-01

Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung MetastasesNCT00588913 · 2006-01-01

Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the LungNCT00301730 · 2005-10-01

Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System LymphomaNCT00006264 · 2000-07-01

Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast CancerNCT00006228 · 2000-07-01

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate CancerNCT00020254 · 2000-06-01

Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian CancerNCT00019916 · 2000-06-01

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast CancerNCT00022230 · 2000-01-01

Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast CancerNCT00005993 · 1999-05-01

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerNCT00003408 · 1998-04-01

Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsNCT00003125 · 1998-01-01

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerNCT00003199 · 1997-11-01

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsNCT00019331 · 1997-10-01

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast CancerNCT00008203 · 1996-05-01

Biological Therapy in Treating Women With Metastatic Breast CancerNCT00002780 · 1996-05-01

Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerNCT00019084 · 1996-02-01

Biological Therapy in Previously Treated Patients With Non-small Cell Lung CancerNCT00003090 · 1996-01-01

Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerNCT00002616 · 1995-02-01

Biological Therapy in Treating Patients With Prostate CancerNCT00002637 · 1995-01-01

Common conditions

Leading sponsors

National Cancer Institute (NCI)6 Masonic Cancer Center, University of Minnesota2 Roger Williams Medical Center2 AIDS Malignancy Consortium1 Cancer Biotherapy Research Group1 Cancer Research UK1 Cancer Treatment Centers of America1 Fred Hutchinson Cancer Center1 Georgetown University1 Herbert Irving Comprehensive Cancer Center1 Memorial Sloan Kettering Cancer Center1 St. Luke's Medical Center1 Tokyo Women's Medical University1 University of Illinois at Chicago1

Trial status mix

COMPLETED13

TERMINATED4

UNKNOWN3

WITHDRAWN1

Phase mix

PHASE215

PHASE110

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.